- Home
- BNTC vs SRBK Comparison
BNTC vs SRBK Comparison
Compare BNTC & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- SRBK
- Stock Information
- Founded
- BNTC 1995
- SRBK 1887
- Country
- BNTC United States
- SRBK United States
- Employees
- BNTC N/A
- SRBK N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- SRBK
- Sector
- BNTC Health Care
- SRBK
- Exchange
- BNTC Nasdaq
- SRBK Nasdaq
- Market Cap
- BNTC 88.1M
- SRBK 104.5M
- IPO Year
- BNTC N/A
- SRBK N/A
- Fundamental
- Price
- BNTC $10.30
- SRBK $11.99
- Analyst Decision
- BNTC Buy
- SRBK
- Analyst Count
- BNTC 6
- SRBK 0
- Target Price
- BNTC $23.83
- SRBK N/A
- AVG Volume (30 Days)
- BNTC 82.8K
- SRBK 18.8K
- Earning Date
- BNTC 02-11-2025
- SRBK 01-01-0001
- Dividend Yield
- BNTC N/A
- SRBK N/A
- EPS Growth
- BNTC N/A
- SRBK N/A
- EPS
- BNTC N/A
- SRBK 0.11
- Revenue
- BNTC N/A
- SRBK $30,867,000.00
- Revenue This Year
- BNTC N/A
- SRBK N/A
- Revenue Next Year
- BNTC N/A
- SRBK N/A
- P/E Ratio
- BNTC N/A
- SRBK $105.06
- Revenue Growth
- BNTC N/A
- SRBK 164.18
- 52 Week Low
- BNTC $2.70
- SRBK $8.94
- 52 Week High
- BNTC $13.29
- SRBK $12.76
- Technical
- Relative Strength Index (RSI)
- BNTC 41.00
- SRBK 56.32
- Support Level
- BNTC $10.20
- SRBK $11.78
- Resistance Level
- BNTC $11.39
- SRBK $11.95
- Average True Range (ATR)
- BNTC 0.87
- SRBK 0.18
- MACD
- BNTC -0.19
- SRBK -0.03
- Stochastic Oscillator
- BNTC 3.58
- SRBK 41.92
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.
About SRBK SR Bancorp Inc. Common stock
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.